10x Genomics (TXG) Net Income towards Common Stockholders Growth (1y) (2019 - 2026)
Powered by 
Analysis
10x Genomics (TXG) Net Income towards Common Stockholders Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | 8.66% |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | 56.76% |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | 7.74% |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | -11.91% |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | -3.94% |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | 179.36% |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | 16.87% |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | -66.31% |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | -927.63% |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | -151.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -151.92% |
| Mar 31, 2026 | 60.80% |
| Dec 31, 2025 | 66.85% |
| Sep 30, 2025 | 23.16% |
| Jun 30, 2025 | 191.14% |
| Mar 31, 2025 | 42.69% |
| Dec 31, 2024 | -0.16% |
| Sep 30, 2024 | 61.55% |
| Jun 30, 2024 | 39.28% |
| Mar 31, 2024 | -18.13% |
| Dec 31, 2023 | -184.36% |
| Sep 30, 2023 | -121.85% |
| Jun 30, 2023 | 3.17% |
| Mar 31, 2023 | -19.65% |
| Dec 31, 2022 | 6.69% |
| Sep 30, 2022 | -144.10% |
| Jun 30, 2022 | -483.22% |
| Mar 31, 2022 | -267.18% |
| Dec 31, 2021 | 95.56% |
| Sep 30, 2021 | 73.92% |